MARINUS PHARMACEUTICALS INC (MRNS) Stock Price, Quote, News and Overview
NASDAQ:MRNS - Nasdaq - US56854Q2003 - Common Stock - Currency: USD
MRNS Quote, Performance and Key Statistics
MARINUS PHARMACEUTICALS INC
NASDAQ:MRNS (2/5/2025, 8:15:19 PM)
After market: 0.55 0 (0%)0.55
+0 (+0.62%)
The current stock price of MRNS is 0.55 USD. In the past month the price increased by 3.07%. In the past year, price decreased by -94.55%.
MRNS Latest News, Press Releases and Analysis
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPY, HEES, MRNS on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MRNS, RHE, SSY, CTV on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates OMIC, MRNS, VCSA on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OMIC, MRNS, VCSA, LBRDA on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRNS, VCSA, MHLD on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
MRNS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 82.81 | 799.50B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 29.06 | 380.66B | ||
| JNJ | JOHNSON & JOHNSON | 15.48 | 372.43B | ||
| MRK | MERCK & CO. INC. | 11.74 | 226.83B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.62 | 219.98B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.86 | 219.54B | ||
| PFE | PFIZER INC | 8.5 | 149.84B | ||
| SNY | SANOFI-ADR | 13.51 | 134.13B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 51.03 | 121.10B | ||
| ZTS | ZOETIS INC | 30.5 | 79.26B | ||
| GSK | GSK PLC-SPON ADR | 9.11 | 76.92B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.09 | 42.39B |
Related stock screener links
About MRNS
Company Profile
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. The company is headquartered in Radnor, Pennsylvania and currently employs 165 full-time employees. The company went IPO on 2014-07-31. The firm is engaged in the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus, which includes the use of ZTALMY (ganaxolone). Its U.S. Food and Drug Administration (FDA) approved the Company’s new drug application for the use of ZTALMY oral suspension CV for the treatment of seizures associated with Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) in patients two years of age and older. The firm is also developing ganaxolone for the treatment of other rare genetic epilepsies, including Tuberous Sclerosis Complex (TSC) and for the treatment of Refractory Status Epilepticus (RSE). The company is developing ganaxolone in formulations for two different routes of administration: intravenous (IV) and oral to maximize therapeutic reach for adult and pediatric patients in acute and chronic care settings.
Company Info
MARINUS PHARMACEUTICALS INC
5 Radnor Corporate Center Suite 500, 100 Matsonford Rd
Radnor PENNSYLVANIA 19087 US
CEO: Scott Braunstein
Employees: 165
Company Website: https://marinuspharma.com/
Investor Relations: https://ir.marinuspharma.com
Phone: 14848014670
MRNS FAQ
What is the stock price of MRNS?
The current stock price of MRNS is 0.55 USD.
What is the symbol for MARINUS PHARMACEUTICALS INC stock?
The exchange symbol of MARINUS PHARMACEUTICALS INC is MRNS and it is listed on the Nasdaq exchange.
On which exchange is MRNS stock listed?
MRNS stock is listed on the Nasdaq exchange.
Is MRNS a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for MRNS, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of MRNS.
Does MRNS stock pay dividends?
MRNS does not pay a dividend.
What is the Price/Earnings (PE) ratio of MRNS?
MRNS does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.44).
What is the Short Interest ratio of MRNS stock?
The outstanding short interest for MRNS is 4.73% of its float.
MRNS Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to MRNS. When comparing the yearly performance of all stocks, MRNS is a bad performer in the overall market: 85.09% of all stocks are doing better.
MRNS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MRNS. Both the profitability and financial health of MRNS have multiple concerns.
MRNS Financial Highlights
Over the last trailing twelve months MRNS reported a non-GAAP Earnings per Share(EPS) of -2.44. The EPS increased by 7.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -220.81% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
MRNS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 74% to MRNS. The Buy consensus is the average rating of analysts ratings from 13 analysts.
For the next year, analysts expect an EPS growth of 19.91% and a revenue growth 9.81% for MRNS